KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBT Margin (2016 - 2025)

Quest Diagnostics' EBT Margin history spans 17 years, with the latest figure at 11.76% for Q4 2025.

  • For Q4 2025, EBT Margin rose 35.0% year-over-year to 11.76%; the TTM value through Dec 2025 reached 11.94%, up 4.0%, while the annual FY2025 figure was 11.94%, 4.0% up from the prior year.
  • EBT Margin for Q4 2025 was 11.76% at Quest Diagnostics, up from 11.65% in the prior quarter.
  • Across five years, EBT Margin topped out at 32.04% in Q2 2021 and bottomed at 4.67% in Q4 2022.
  • The 5-year median for EBT Margin is 13.06% (2023), against an average of 14.52%.
  • The largest annual shift saw EBT Margin skyrocketed 1808bps in 2021 before it tumbled -1887bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 18.29% in 2021, then crashed by -74bps to 4.67% in 2022, then soared by 122bps to 10.36% in 2023, then grew by 10bps to 11.41% in 2024, then grew by 3bps to 11.76% in 2025.
  • Per Business Quant, the three most recent readings for DGX's EBT Margin are 11.76% (Q4 2025), 11.65% (Q3 2025), and 13.91% (Q2 2025).